NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Revised to be consistent.

...

Data ElementDescription
NCI ID

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

DCP IDIdentifier assigned to this trial by the DCP (Division of Cancer Prevention).

Include Page
Trial Attribute CTEP ID - Include v4.4
Trial Attribute CTEP ID - Include v4.4
 

CTEP IDIdentifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program).

Include Page
Trial Attribute DCP ID - Include v4.4
Trial Attribute DCP ID - Include v4.4
 

Lead Organization

Include Page
Trial Attribute Lead Org Name - Include v4.4
Trial Attribute Lead Org Name - Include v4.4
For more information, refer to Abstracting Sponsors and Responsible Parties.

Sponsor

Include Page
Trial Attribute Sponsor - Include v4.4
Trial Attribute Sponsor - Include v4.4
 For more information, refer to Abstracting Sponsors and Responsible Parties.

Send Trial Information to ClinicalTrials.gov

Value indicating whether the system sends the trial information to ClinicalTrials.gov in the automated nightly batch updates (via FTP):

  • Yes. The system sends the trial information.
  • No. The system does not send the trial information.
  • N/A. The trial does not satisfy other criteria.

For more information, refer to Abstracting NCI-Specific Information.

Completion Date

Date on which final data was collected for the trial, or the date on which that is expected to happen. For more information, refer to Abstracting Trial Statuses.

Processing Status

Include Page
Trial Attribute Current Trial Processing Status - Include v4.4
Trial Attribute Current Trial Processing Status - Include v4.4
 For more information, refer to Abstracting Trial Statuses.

Current trial status

Include Page
Trial Attribute Current Trial Status - Include v4.4
Trial Attribute Current Trial Status - Include v4.4
 For more information, refer to Abstracting Trial Statuses.

Primary Completion Date

Include Page
Trial Attribute Primary Completion Date - Include v4.4
Trial Attribute Primary Completion Date - Include v4.4
 For more information, refer to Abstracting Trial Statuses.

Primary Completion Type

Include Page
Trial Attribute Primary Completion Date Type

Value indicating whether the completion date is the one on which the trial is expected to complete (Anticipated), or the date on which it actually completed (Actual).

- Include v4.4
Trial Attribute Primary Completion Date Type - Include v4.4
 For more information, refer to Abstracting Trial Statuses.

Section 801 Indicator

Value

indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801.

indicating 

Include Page
Trial Attribute 801 Indicator - Include v4.4
Trial Attribute 801 Indicator - Include v4.4
For more information, refer to Abstracting Regulatory Information.

Processing CommentsAny comments that an abstractor has recorded for this trial, on the Trial Identification page or Dashboard Details page. For more information, refer to Tracking and Managing Trial Records.
CTRO Override Flag CommentsAny comments that an abstractor has recorded (with the "Send Trial Information to ClinicalTrials.gov?" value) for this trial. For more information, refer to Abstracting NCI-Specific Information.

...